Market Overview

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Share:
Related GILD
Icahn, Gilead, GE Lead Top Insider Trades Of The Week
Rebound For Big Biotech ETF Will Require Some Patience
Gilead: I Want To Sell But I Can't (Seeking Alpha)
Related CELG
Icahn, Gilead, GE Lead Top Insider Trades Of The Week
Rebound For Big Biotech ETF Will Require Some Patience
Transportation, Jets ETFs Speed Up As Oil Falls Below $28 (Investor's Business Daily)

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.

Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.

Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.

Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

Posted-In: Biotechnology Industry Large-Cap PEG ratioTrading Ideas

 

Related Articles (ALXN + BIIB)

View Comments and Join the Discussion!

Get Benzinga's Newsletters